Targeting fibrosis: Mechanisms and clinical trials
M Zhao, L Wang, M Wang, S Zhou, Y Lu… - Signal transduction and …, 2022 - nature.com
Fibrosis is characterized by the excessive extracellular matrix deposition due to
dysregulated wound and connective tissue repair response. Multiple organs can develop …
dysregulated wound and connective tissue repair response. Multiple organs can develop …
Macrophage polarization and its role in liver disease
C Wang, C Ma, L Gong, Y Guo, K Fu, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
Macrophages are important immune cells in innate immunity, and have remarkable
heterogeneity and polarization. Under pathological conditions, in addition to the resident …
heterogeneity and polarization. Under pathological conditions, in addition to the resident …
The immunological and metabolic landscape in primary and metastatic liver cancer
X Li, P Ramadori, D Pfister, M Seehawer… - Nature Reviews …, 2021 - nature.com
The liver is the sixth most common site of primary cancer in humans, and generally arises in
a background of cirrhosis and inflammation. Moreover, the liver is frequently colonized by …
a background of cirrhosis and inflammation. Moreover, the liver is frequently colonized by …
MicroRNA interplay between hepatic stellate cell quiescence and activation
D Ezhilarasan - European Journal of Pharmacology, 2020 - Elsevier
Hepatic stellate cells (HSCs) activation play a significant role in the progression of hepatic
fibrosis. During chronic liver diseases, hepatocytes are damaged severely and secrete …
fibrosis. During chronic liver diseases, hepatocytes are damaged severely and secrete …
Liver fibrosis: Pathophysiology and clinical implications
J Berumen, J Baglieri, T Kisseleva… - WIREs mechanisms of …, 2021 - Wiley Online Library
Liver fibrosis is a clinically significant finding that has major impacts on patient morbidity and
mortality. The mechanism of fibrosis involves many different cellular pathways, but the major …
mortality. The mechanism of fibrosis involves many different cellular pathways, but the major …
Hepatocellular carcinoma: a narrative review on current knowledge and future prospects
B Alawyia, C Constantinou - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement Hepatocellular carcinoma is the fourth leading cause of cancer-related
deaths worldwide and its associated mortality rate is expected to rise within the next decade …
deaths worldwide and its associated mortality rate is expected to rise within the next decade …
Cellular and molecular mechanisms underlying liver fibrosis regression
A Caligiuri, A Gentilini, M Pastore, S Gitto, F Marra - Cells, 2021 - mdpi.com
Chronic liver injury of different etiologies may result in hepatic fibrosis, a scar formation
process consisting in altered deposition of extracellular matrix. Progression of fibrosis can …
process consisting in altered deposition of extracellular matrix. Progression of fibrosis can …
Chlorogenic acids: A pharmacological systematic review on their hepatoprotective effects
H Xue, M Wei, L Ji - Phytomedicine, 2023 - Elsevier
Background Liver diseases have a negative impact on global health and are a leading
cause of death worldwide. Chlorogenic acids (CGAs), a family of esters formed between …
cause of death worldwide. Chlorogenic acids (CGAs), a family of esters formed between …
Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota
C Wang, C Ma, K Fu, LH Gong, YF Zhang… - Frontiers in …, 2021 - frontiersin.org
Liver fibrosis is a chronic pathological process that various pathogenic factors lead to
abnormal hyperplasia of hepatic connective tissue, and its main feature is the excessive …
abnormal hyperplasia of hepatic connective tissue, and its main feature is the excessive …
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
R Benedé-Ubieto, FJ Cubero, YA Nevzorova - Gut microbes, 2024 - Taylor & Francis
ABSTRACT Obesity, insulin resistance (IR), and the gut microbiome intricately interplay in
Metabolic-associated Steatotic Liver Disease (MASLD), previously known as Non-Alcoholic …
Metabolic-associated Steatotic Liver Disease (MASLD), previously known as Non-Alcoholic …